Rezultaty
The public project website will serve several purposes, including a) being the central go-to-point for consortium members to look up contact information of other partners and to log into the confidential intranet, b) providing a concise overview of the project’s goals, its work packages, and the scientific background to the general public, and c) continuously informing patients and the general public on project-related events, publications, downloads and newsworthy developments. Patient-relevant information will be made available in several common EU languages.
Project brochure (for patients, laymen and scientists) and professional templatesThe project brochure will be a handy flyer or folder that summarises the project’s vision, why it matters, its key objectives, the partner institutions, basic facts (start date, duration, number of countries, funding amount etc.) for transparency, the website URL, and contact information of the scientific coordinator and the project Manager.
VideoA video will be produced for the general public and patients (target audience) explaining the problem of chronic pain and the secondary problems, the lack of adequate treatment for many chronic pain patients, as well as the key goals of the QSPainRelief project in form of animated filmed interviews with the coordinator and WP leaders.
Jointly with one of the relevant patient organisations, the first layman event will take place within the first 6 months, including a Q & A session at a convenient location (most likely connected to an SC Meeting) where partnering clinicians and researchers explain the scope of the project and answer questions of patients and the general public.
Document identifying the selected drugs out of the list of EU approved medications their simulated CNS drug distribution and ontarget functional concentration derived from clinical studies
Publikacje
Autorzy:
Adrián Ricarte, James A. R. Dalton, Jesús Giraldo
Opublikowane w:
Journal of Chemical Information and Modeling, Numer 61/3, 2021, Strona(/y) 1251-1274, ISSN 1549-9596
Wydawca:
American Chemical Society
DOI:
10.1021/acs.jcim.0c00890
Autorzy:
Pedro Renault, Jesús Giraldo
Opublikowane w:
International Journal of Molecular Sciences, Numer 22/1, 2021, Strona(/y) 187, ISSN 1422-0067
Wydawca:
Multidisciplinary Digital Publishing Institute (MDPI)
DOI:
10.3390/ijms22010187
Autorzy:
Oscar Díaz, Pedro Renault, and Jesús Giraldo
Opublikowane w:
ACS Omega, Numer 7, 42, 2022, Strona(/y) 37873–37884, ISSN 2470-1343
Wydawca:
American Chemical Society (ACS) Publications
DOI:
10.1021/acsomega.2c04980
Autorzy:
Óscar Díaz, Victor Martín, Pedro Renault, David Romero, Antoni Guillamon, Jesús Giraldo
Opublikowane w:
Drug Discovery Today, Numer Volume 28, Numer 2, 2023, ISSN 1359-6446
Wydawca:
Elsevier BV
DOI:
10.1016/j.drudis.2022.103441
Autorzy:
Agustín Bruzzese, James A. R. Dalton, Jesús Giraldo
Opublikowane w:
Scientific Reports, Numer 10/1, 2020, ISSN 2045-2322
Wydawca:
Nature Publishing Group
DOI:
10.1038/s41598-020-77072-4
Autorzy:
Bertayli M,Hijma H, Bakker W, Groeneveld GJ, Elassaiss-Schaap S
Opublikowane w:
PAGE. Abstracts of the Annual Meeting of the Population Approach Group in Europe., 2022
Wydawca:
Population Approach Group in Europe
Wyszukiwanie danych OpenAIRE...
Podczas wyszukiwania danych OpenAIRE wystąpił błąd
Brak wyników